NCT05344456

Brief Summary

Premature ventricular contractions (PVC) are common phenomenon and occasionally retrograde conduction from ventricle to atrium occurs and may cause pacemaker mediated tachycardia. In response certain Abbott (former St Jude Medical) pacemakers have a specific PVC response algorithm ''Atrial Pace''. In this algorithm the PVARP (Post Ventricular Atrial Refractory Period) is extended to 480ms but the initial 150ms of the PVARP is deemed absolute. If atrial sensed event occurs after absolute PVARP the PVARP terminates and atrial pace follows after 330ms alert period. Two case reports exists where patients atrial tachycardia were suspected to be induced by this algorithm. In Helsinki University Hospital an index patient with multiple atrial tachycardia episodes was recognized in late 2020 where the cause of the tachycardias was suspected to be the PVC response algorithm ''Atrial Pace''. After programming the algorithm from Atrial Pace to off mode the patient had none atrial tachycardias during 2021. After investigating all the patients with physiological ICD (Implantable Cardioverter Defibrillator) or CRT-D (Cardiac Resynchronization Therapy) device and analyzing remote monitoring transmissions from the year 2020 we found 25 patients with similar atrial tachycardia episodes possibly induced by the PVC response ''Atrial Pace''.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
16 days until next milestone

Study Start

First participant enrolled

May 11, 2022

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2023

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

21 days

First QC Date

April 14, 2022

Last Update Submit

February 24, 2024

Conditions

Keywords

premature ventricular complexpacemakerarrythmia

Outcome Measures

Primary Outcomes (2)

  • Number of atrial tachycardia episodes per participant which is initiated after PVC followed by atrial sensed event and atrial pace after 330ms delay.

    Atrial tachycardia episode is considered as an episode which duration is \>30s and atrial rate \> 180 beats per minute.

    The number of these episodes is compared between year 2020 and 12 months preceding the change in the programming setting and 12 months afterwards.

  • Number of any atrial tachycardia episodes and overall duration of atrial tachycardia episodes per participant.

    Atrial tachycardia episode is considered as an episode which duration is \>30s and atrial rate \> 180 beats per minute.

    The number of these episodes and overall duration of all atrial tachycardia episodes is compared between year 2020 and 12 months preceding the change in the programming setting and 12 months afterwards.

Secondary Outcomes (1)

  • Composite Change in the quality of life analyzed with EQ-5D-3L and ICD8 questionaries'.

    baseline and after 12 months surveillance

Study Arms (1)

PVC response ''Off''

EXPERIMENTAL
Device: Change in the device PVC algorithm to ''Off''

Interventions

PVC algorithm change from Atrial Pace mode to Off

PVC response ''Off''

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ST Jude Medical or Abbott physiological ICD or CRT-D device
  • PVC response setting ''Atrial Pace''
  • Atrial tachycardia episode duration \> 30s preceded by ventricular extrasystole and atrial pace in year 2020 or 2021

You may not qualify if:

  • Permanent atrial fibrillation, duration ≥ 6 months before the enrollment to the study
  • PVC response has been switched off before enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helsinki University Central Hospital

Helsinki, Finland

Location

Related Publications (2)

  • Friedman DJ, Chasten T, Anderson K, Mullenix J, Rider K, Sun AY. Premature ventricular contraction response-induced new-onset atrial fibrillation. HeartRhythm Case Rep. 2018 Nov 30;5(3):120-123. doi: 10.1016/j.hrcr.2018.11.012. eCollection 2019 Mar. No abstract available.

    PMID: 30891406BACKGROUND
  • Liu Y, Yuan X. Logic Analysis of Arrhythmia Triggered by Pacemaker Special Functions - An Educational Presentation. Braz J Cardiovasc Surg. 2021 Jun 1;36(3):412-415. doi: 10.21470/1678-9741-2020-0630.

    PMID: 34387977BACKGROUND

MeSH Terms

Conditions

Ventricular Premature ComplexesArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Cardiac Complexes, PrematureHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Markus Sane

    Helsinki University Central Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D, PhD, Cardiologist

Study Record Dates

First Submitted

April 14, 2022

First Posted

April 25, 2022

Study Start

May 11, 2022

Primary Completion

June 1, 2022

Study Completion

August 20, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations